Hip Fractures (ICD-10 72.01-72.2)
14
4
4
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (14)
How TENS Affects Pain, Medication Use, and Muscle Function in Older Adults With Hip Fractures
Mobility and Activity of Daily Living Outcomes After a Hip Fracture.
Home Rehabilitation After Hip Fracture
10-Year Survival After Acute Hip Fracture in Patients With Preclinical/Clinical Alzheimer Pathology
Population Pharmacokinetics and Pharmacodynamics of Ciprofol
Effect of Preoperative PENG Block on Spinal Anesthesia Positioning and Postoperative Analgesia in Hip Fracture Surgery
Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia
Frailty Intervention in Postoperative Hip Fracture Inpatients
Tactile Incentiviser Improves Partial Weight Bearing After Lower-Limb Surgery
Rehabilitation in the Home After Hip Fracture
Risk Early Warning Management for Postoperative Hip Fracture Rehabilitation and Delirium Prevention in Elderly Patients
Effect of Transcranial Direct Current Stimulation on Postoperative Delirium in Elderly Patients
Time on Feet After Hip Fracture Event
Traumatologic Acute Pain Management With Fentanyl Transdermal Therapeutic System (TTS)